Lion Point Capital as of Dec. 31, 2024
Portfolio Holdings for Lion Point Capital
Lion Point Capital holds 19 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 13.3 | $2.5M | 37k | 69.04 | |
| Milestone Pharmaceuticals (MIST) | 12.7 | $2.4M | 1.0M | 2.36 | |
| Geron Corporation (GERN) | 9.3 | $1.8M | 500k | 3.54 | |
| Ardelyx (ARDX) | 8.9 | $1.7M | 335k | 5.07 | |
| Fennec Pharmaceuticals (FENC) | 6.5 | $1.2M | 196k | 6.32 | |
| Bridgebio Pharma (BBIO) | 5.8 | $1.1M | 40k | 27.44 | |
| Mineralys Therapeutics (MLYS) | 5.1 | $973k | 79k | 12.31 | |
| Kiniksa Pharmaceuticals Ord Shs Cl A (KNSA) | 4.8 | $908k | 46k | 19.78 | |
| Biohaven (BHVN) | 4.4 | $848k | 23k | 37.35 | |
| Benitec Biopharma Com New (BNTC) | 4.1 | $783k | 62k | 12.63 | |
| Syndax Pharmaceuticals (SNDX) | 3.8 | $727k | 55k | 13.22 | |
| Jasper Therapeutics Com New (JSPR) | 3.6 | $684k | 32k | 21.38 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 3.5 | $673k | 64k | 10.51 | |
| Disc Medicine (IRON) | 3.5 | $672k | 11k | 63.40 | |
| Bluebird Bio Com New | 3.4 | $658k | 79k | 8.34 | |
| Arcutis Biotherapeutics (ARQT) | 3.4 | $645k | 46k | 13.93 | |
| Regenxbio Inc equity us cm (RGNX) | 2.3 | $446k | 58k | 7.73 | |
| Seres Therapeutics | 1.5 | $283k | 341k | 0.83 | |
| Spruce Biosciences (SPRB) | 0.2 | $32k | 75k | 0.42 |
